| abstract |
The anti-inflammatory combination finds application for treatmentnprevention of acute or chronic musculoskeletal inflammatory processes.nIt has been reduced gastric injuries while in use, while preservingnor enhances the anti-inflammatory effect. It consists of 4- (4-bromophenyl) -2-methyl-n1,2,3,4-tetrahydroisoquinoline hydrochloride and non-steroidal anti-inflammatory drugsnpreparations which can be administered as separate pharmaceutical compositionsnor as a single composition. |